Idorsia's Q3 Net Loss Narrows; Net Revenue Up

02:27 AM EDT, 10/29/2026 (MT Newswires) -- Idorsia (IDIA.SW) logged 53 million francs in net loss for the third quarter, compared with a net loss of 86 million francs a year ago. Loss per share moved to 0.20 franc from 0.40 franc year over year, a Thursday filing showed. For the three months ended Sept. 30, net revenue was 62 million francs versus 41 million francs previously, the Swiss-listed biopharmaceutical group added. Analysts polled by FactSet were expecting 53.3 million francs in sales, 52.5 million francs in net loss, and a loss per share of 0.20 franc. Looking ahead, the company affirmed its guidance of an improvement in operating loss in 2026.